Joel Habener: Difference between revisions
Content deleted Content added
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Short description|Medical researcher}}'''Joel Habener''' is a Professor of Medicine at [[Harvard Medical School]]. |
{{Short description|Medical researcher}}'''Joel Habener''' is a Professor of Medicine at [[Harvard Medical School]]. |
||
Habener worked with [[Svetlana Mojsov]] on elucidating the role of [[incretin]] hormones such as [[Glucagon-like peptide-1|Glucagon-like peptide-1 (GLP-1)]] and [[Glucagon-like peptide-2|Glucagon-like peptide-2 (GLP-2)]]. Habener received credit for the work on hormones |
Habener worked with [[Svetlana Mojsov]] on elucidating the role of [[incretin]] hormones such as [[Glucagon-like peptide-1|Glucagon-like peptide-1 (GLP-1)]] and [[Glucagon-like peptide-2|Glucagon-like peptide-2 (GLP-2)]]. Habener received credit for the work on hormones when Mosjov was not credited.<ref>{{Cite web |last=Molteni |first=Megan |last2=Chen |first2=Elaine |date=27 September 2023 |title=The Ozempic revolution is rooted in the work of Svetlana Mojsov, yet she’s been edged out of the story |url=https://www.statnews.com/2023/09/27/weight-loss-obesity-glp1-svetlana-mojsov/ |access-date=2023-10-09 |website=STAT |language=en-US}}</ref> Habener was awarded the 2020 [[Warren Alpert Foundation Prize]] along with [[Daniel J. Drucker|Daniel Drucker]] and Jens Juul Holst.<ref>{{Cite web|url=https://warrenalpert.org/prize-recipients|title=Prize Recipients | Warren Alpert Foundation Prize|website=warrenalpert.org}}</ref> He was elected to the [[National Academy of Sciences]] in 2020.<ref>{{Cite web|url=http://www.nasonline.org/news-and-multimedia/news/2020-nas-election.html|title=2020 NAS Election|website=www.nasonline.org}}</ref> In 2021 he was awarded the [[Canada Gairdner International Award]].<ref>[https://gairdner.org/winners/current-winners/ Canada Gairdner International Award 2021]</ref> |
||
==References== |
==References== |
||
Revision as of 08:22, 10 November 2023
Joel Habener is a Professor of Medicine at Harvard Medical School.
Habener worked with Svetlana Mojsov on elucidating the role of incretin hormones such as Glucagon-like peptide-1 (GLP-1) and Glucagon-like peptide-2 (GLP-2). Habener received credit for the work on hormones when Mosjov was not credited.[1] Habener was awarded the 2020 Warren Alpert Foundation Prize along with Daniel Drucker and Jens Juul Holst.[2] He was elected to the National Academy of Sciences in 2020.[3] In 2021 he was awarded the Canada Gairdner International Award.[4]
References
- ^ Molteni, Megan; Chen, Elaine (27 September 2023). "The Ozempic revolution is rooted in the work of Svetlana Mojsov, yet she's been edged out of the story". STAT. Retrieved 2023-10-09.
- ^ "Prize Recipients | Warren Alpert Foundation Prize". warrenalpert.org.
- ^ "2020 NAS Election". www.nasonline.org.
- ^ Canada Gairdner International Award 2021
| International | |
|---|---|
| National | |
| Other | |
   | This biographical article related to a physician in the United States is a stub. You can help Wikipedia by expanding it. |